Characterisation of GEA 3175 on human platelets;: comparison with S-nitroso-N-acetyl-D,L-Penicillamine (cas 1113-41-3)

Add time:08/20/2019    Source:sciencedirect.com

By comparing the effect of two nitric oxide (NO)-containing compounds, we found that S-nitroso-N-acetyl-d,l-penicillamine (SNAP), but not GEA 3175 (1,2,3,4-Oxatriazolium,3-(3-chloro-2-metylphenyl)-5-[[(4-methylphenyl)sulfonyl]amino]-, hydroxide inner salt), released NO. Despite this, both drugs elevated cyclic guanosine 3′,5′-monophosphate (cGMP) levels in human platelets. However, SNAP was more effective after short exposure times (5 and 20 s). The compounds also inhibited thrombin-induced rises in cytosolic Ca2+. Time studies revealed that the action of SNAP rapidly declined by increasing the length of incubation (from 5 s to 30 min). This desensibilisation phenomenon mainly involved the release of Ca2+ from intracellular stores. In comparison, GEA 3175-induced inhibition of cytosolic Ca2+ signalling was much more long-lasting. The soluble guanylyl cyclase (sGC) inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) reversed the effect of GEA 3175 on cytosolic Ca2+. Consequently, this inhibition depends solely on the increase in cGMP. In summary, differences between GEA 3175 and SNAP were observed in NO releasing, cGMP elevating and Ca2+ suppressive properties.

We also recommend Trading Suppliers and Manufacturers of L-Penicillamine (cas 1113-41-3). Pls Click Website Link as below: cas 1113-41-3 suppliers

Prev:Determination of the l-isomer in d-penicillamine by derivatization liquid chromatography
Next:Research letterMutagenicity experiments on l-cysteine and d-penicillamine using V79 cells as indicators and for metabolic activation)